Summary

Contraceptive Market Trends and Forecast
The future of the global contraceptive market looks promising with opportunities in the household, clinic, and hospital markets. The global contraceptive market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing awareness of family planning, the growing access to contraceptive methods, and the rising focus on women’s health.

• Lucintel forecasts that, within the product type category, device is expected to witness higher growth over the forecast period.
• Within the end use category, household is expected to witness the highest growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.
Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Contraceptive Market
The contraceptive market is going through an era of change, fueled by shifting social attitudes, technological innovation, and an increased emphasis on personal reproductive choice. These emerging trends are reconfiguring product design, accessibility, and consumer demand. As the need for personalized, efficient, and user-friendly birth control increases worldwide, companies are innovating to provide a broader range of options beyond the conventional hormonal pills to include new delivery systems and non-hormonal products. Such changes form the pillars of unmet needs and enabling people to make the best possible decisions regarding family planning.
• Emergence of Over-the-Counter Contraceptives: One major upcoming trend is the rising use and availability of oral contraceptives for purchase over the counter without a prescription. The United States FDA approval of Opal as an OTC daily oral contraceptive is the perfect example. The effect is dramatically enhanced access to birth control, especially for those who encounter obstacles for clinic visits or prescriptions. The trend equips consumers with more autonomy over their reproductive health choices, which could lead to lower unintended pregnancies as well as increased market penetration through channels other than traditional pharmacies.
• Emphasis on Non-Hormonal Contraceptive Methods: There is increasing focus on the development and release of non-hormonal forms of contraception. This ranges from new barrier technologies, improved spermicides, and exploration of novel hormone-free mechanisms. The effect is offering alternatives to those who suffer from unwanted side effects with hormonal methods or possess medical contraindications. This offers a niche in the market for drug-free or hormone-free users, creating diversification and satisfying an underserved population need for more methods of contraception.
• Male Contraceptive Development: In the past, contraception was mainly female-oriented. The important new trend is the rapid development and research into reliable and reversible male contraceptive techniques, such as hormonal gels, pills, and non-hormonal options like reversible vasectomies. The result is a more balanced sharing of family planning responsibility between a couple. This trend can potentially grow the overall market for contraceptives and encourage shared decision-making on reproductive health, and is a significant development in the contraceptive market.
• Integration of Digital Health and Telemedicine: Adoption of digital health platforms and telemedicine across the board is having a transformative effect on the contraceptive market. This phenomenon consists of online doctor consultations, e-prescribing services, cycle tracking and pill reminder mobile applications, and remote monitoring of contraceptive use. The effect is greater convenience, private access to contraceptive supplies and counseling, particularly in distant or underserved populations. This integration enhances user compliance, offers individualized support, and simplifies the process of getting and managing contraception, increasing it to be more user-friendly and accessible.
• Long-Acting Reversible Contraceptives Innovation: Although LARCs (implants and intrauterine devices) are not innovative, the trend is to continue innovating to enhance their usability, minimize side effects, and increase their duration of action. This involves smaller IUDs, novel hormone compositions, and simpler insertion/removal methods. The effect is greater LARC preference because of their high efficacy, low user intervention, and long-term pregnancy protection. This trend plays a major role in minimizing unplanned pregnancies by offering highly effective, "set-it-and-forget-it" family planning solutions.
All these new trends are deeply transforming the contraceptive market by democratizing availability through OTC, expanding choice with non-hormonal and male alternatives, improving user experience with digital health, and optimizing the efficacy and ease of LARCs. This combined transformation indicates an era of more accessible, inclusive, and individualized reproductive healthcare solutions around the world.

Recent Developments in the Contraceptive Market
The contraceptive market recently went through a number of critical developments, mirroring its continued evolution to suit changing healthcare requirements and societal needs. These are fueled by worldwide commitment to reproductive rights, a growing awareness concerning family planning, and ongoing works aimed at eliminating unwanted pregnancies and sexually transmitted diseases. These advancements include breakthroughs in drug formulations, device technology, and availability, overall reshaping the landscape of birth control methodologies and giving people more control over their reproductive lives around the globe.
• Approval and Introduction of Over-the-Counter Oral Contraceptives: One of the most revolutionary recent advances is the approval and ensuing introduction of the first over-the-counter (OTC) daily oral contraceptive, like Opal in the United States. This landmark regulatory achievement permits people to buy birth control pills without a prescription from retailers and pharmacies. The effect is significantly increased access to contraception, especially for those with impediments to healthcare access, and it may result in fewer unintended pregnancies and give a broader population the capability to control their reproductive life.
• Innovation in Long-Acting Reversible Contraceptives: More recent advances remain directed towards enhancing LARCs, such as new generations of intrauterine devices (IUDs) and contraceptive implants. These include smaller size for ease of placement, new progestin formulations to minimize side effects, and longer durations of protection. The effect is higher levels of satisfaction and compliance arising from the high level of efficacy, long protection, and low daily effort needed. This drives the market toward more comfortable and dependable long-term birth control options, which attract a wider audience.
• Development in Non-Hormonal Contraceptive Research: There has been increased and serious investment in research and development of new non-hormonal contraceptive technologies for both males and females. This involves investigating new mechanisms of action to stop conception without hormonal interference. The implication is the ability to provide proper alternatives for those who are unable to utilize hormonal contraception because of medical issues or side effects, or just prefer non-hormonal methods. This innovation expands the range of options and hopes to satisfy unmet needs in the market.
• Integration of Digital Health and Telemedicine Platforms: The growth of digital health apps and telemedicine care has become a major innovation in access and management of contraceptives. These apps make it easy to conduct online consultations, e-prescribe, remind on medication, and give customized family planning guidance. The result is greater convenience and modest access to contraceptive services, despite geographical and logistical challenges. This innovation is improving user adherence, continuous support, and facilitating easier access to and management of the desired form of birth control.
• Increased Emphasis on Male Contraceptive Research: The last few years have witnessed a perceptible pick-up in research and clinical trials on male contraceptive options, such as hormonal and non-hormonal options like gels, pills, and reversible procedures. The result is the shift towards more joint responsibility in family planning, expanding the range of contraceptive possibilities beyond female ones. While still largely in developmental stages, this focus signifies a pivotal shift in the contraceptive market, holding immense potential to broaden the choices available to couples globally in the coming years.
These recent advances are altogether transforming the contraceptive market by greatly enhancing accessibility with OTC solutions, improving LARCs' user experience, expanding options through non-hormonal breakthroughs, utilizing digital channels for convenience, and breaking ground in male contraceptive products. This many-sided transformation marks a future of more diverse, friendly, and inclusive family planning options globally.

Strategic Growth Opportunities in the Contraceptive Market
The contraceptive market offers significant strategic growth opportunities across key applications based on an increasing global need for efficient family planning methods, growing awareness of reproductive health, and a persistent demand for enhanced user experiences. As populations globally continue to grow and social norms shift, the demand for varied, accessible, and user-friendly contraceptive methods grows. Recognizing and leveraging these application-specific opportunities is important for industry players to diversify their product offerings, enter new consumer bases, and establish themselves in this rapidly important healthcare market.
• Teenager and Young Adult Segment: This population is an important strategic growth segment because of their growing awareness of sexual health, preference for control over reproductive decisions, and frequently higher levels of unplanned pregnancies. Strategic growth includes the creation of discreet, simple-to-use, and affordable contraception that fits their lifestyle needs, along with easy-to-access educational material. Marketing and distribution needs to engage through digital media and social networking, as well as school-based programs and youth-accessible clinics, to facilitate appropriate outreach and uptake in this key segment.
• Breastfeeding and Postpartum Women: Several women have particular contraceptive requirements during the postpartum interval, particularly those who breastfeed. This market provides a central expansion opportunity for those that are safe for both the mother and the child, that do not disrupt lactation, and that are extremely effective. Strategic expansion is through advocating and developing progestin-only pills, some LARCs such as non-estrogen IUDs and implants, as well as non-hormonal methods. Training of healthcare professionals in postpartum family planning is equally important to tap this segment and meet unmet demand for spacing births.
• Low and Middle-Income Countries: LMICs provide a huge strategic growth potential with high unmet demand for family planning, substantial reproductive-age populations, and persistent government and NGO efforts to expand access to contraceptives. Strategic growth entails the creation and dissemination of low-cost, long-lasting, simple-to-administer contraceptive technologies appropriate for resource-constrained environments. Distribution, education, and over-come cultural barriers will depend upon collaboration with local governments, non-profits, and community health workers.
• Telemedicine and Health Digital Platforms: Implementation of telemedicine and digital health in contraception presents a fast-growing growth opportunity. Strategic expansion entails the creation and implementation of platforms for remote consultations, online prescriptions, medication distribution, and app-based reminders of taking contraceptives. This increases convenience, accessibility, and privacy for the clients, especially in rural or underserved locations, and during times of reduced in-person healthcare access. Such digitalization simplifies the process of access and management of contraception, promoting adherence and satisfaction.
• Male Contraception R&D: Although presently constrained, the strategic potential of male contraception is great and represents a highly unexploited market. Expansion entails considerable investment in research and development to market safe, effective, and reversible male contraceptive options (e.g., hormone gels, non-hormonal pills, reversible vasectomy options). This application responds to the need for mutual responsibility in family planning and can potentially double the size of the global contraceptive user base. Successful development and uptake in this space would transform the market landscape.
These strategic opportunities for growth are heavily influencing the contraceptive market by compelling innovation towards personalized solutions for different populations. By emphasizing the distinct requirements of adolescents, postpartum women, people in LMICs, and using digital health, while at the same time leading the way in male contraception, businesses can increase market reach, enhance reproductive health outcomes across the world, and promote a more inclusive future for family planning decisions.

Contraceptive Market Driver and Challenges
The contraceptive market is influenced by a multifaceted interaction of numerous technological, economic, and regulatory factors. They all act in unison to determine its growth path, competitive environment, and prospects. It is important for stakeholders to comprehend these dynamics in order to create effective strategies. While strong drivers such as growing awareness of reproductive health, official family planning initiatives, and ongoing product development innovation drive market growth, the industry also battles built-in challenges such as social stigma surrounding contraception, possible side effects of current methods, and complicated regulatory approval processes for new products. An in-depth examination of these factors gives a proper insight into the state of the market and its prospects for future growth.
The factors responsible for driving the contraceptive market include:
1. Increasing Awareness about Reproductive Health and Family Planning: One of the key drivers is rising worldwide awareness of reproductive health and family planning needs. Government, non-governmental organization, and healthcare provider education campaigns are educating people about the use of contraceptive methods, their advantages, and safe sexual health behaviors. This increased awareness consequently translates into increased demand for diverse contraceptive methods to avoid unwanted pregnancies and control family size.
2. Encouraging Government Policies and Initiatives: All over the globe, governments are taking active measures in promoting family planning by initiatives, funding schemes, and policies for lowering maternal mortality rates and stabilizing population growth. Subsidies to contraceptive products, free access to family planning services, and education campaigns are popular components of such initiatives. These interventions significantly contribute to making contraceptives more accessible and affordable, particularly in developing nations, thus contributing importantly to market growth.
3. Growing Prevalence of Unwanted Pregnancies: In spite of development, unintended pregnancies continue to be a major world public health issue, which fuels the need for effective birth control. The need to prevent unwanted births due to personal situation, financial reasons, or medical grounds drives people and couples towards seeking sure-shot birth control procedures. This continuous demand forms the basis for a stable and expanding market for all categories of contraceptives.
4. Product Innovation and Technological Advances: Sustained innovation in product and technology development of contraceptive products is one of the key drivers of the market. These involve new oral contraceptive formulations, extended-release reversible contraceptives (LARCs) with enhanced safety profiles, and the introduction of non-hormonal products. These developments provide users with more options, improved efficacy, and reduced side effects, leading to increased user satisfaction and adopting rates.
5. Increasing Female Participation in the Labor Force and Empowerment: The growing engagement of women in the international economy and increased empowerment drive the growth of the contraceptive market. As women seek education and employment, they tend to opt for delayed childbearing or family limitation, which translates to higher use of effective contraception. This change in society towards more female control over reproductive choices drives consistent demand for birth control solutions.

Challenges in the contraceptive market are:
1. Social Stigma and Cultural Barriers: In spite of growing awareness, widespread social stigma and cultural barriers to contraception remain in most areas. Religious dogma, prevailing norms, and the absence of frank conversations regarding sexual health may discourage adoption and consistent use of contraceptive techniques. This is a problem that can only be addressed through sensitive, localized education and community outreach in order to overcome deeply rooted societal attitudes.
2. Side Effects and Health Concerns: Most of the contraceptive methods, especially hormonal ones, are linked to numerous side effects, including mood swings, weight gain, unscheduled bleeding, and apprehensions regarding long-term health hazards (e.g., blood clots). Side effects can result in method discontinuation or hesitation to begin use, creating a huge challenge to market development. Ongoing research into safer products with fewer side effects is vital.
3. Complicated Regulatory Barriers and Long Approval Times: The innovation and market entry of new contraceptives are regulated by strong and complicated regulatory approval procedures globally. These varied regulatory environments, requiring large-scale clinical trials and safety information, are time-consuming and costly to navigate. This long and costly approval pathway can hinder the availability of new products and discourage smaller businesses from entering the market.
The net effect of these drivers and challenges on the contraceptive market is one of both great potential and great challenge. While strong drivers such as rising health consciousness, facilitatory government policies, and ongoing innovation are propelling the market, the industry must aggressively confront lingering social stigma, side effect fears, and challenging regulatory regimes. Overcoming these obstacles through focused education, patient-focused product development, and simplified regulatory routes will be critical to increasing access to effective contraception around the world and enhancing reproductive health outcomes.

List of Contraceptive Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies contraceptive companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the contraceptive companies profiled in this report include-
• Mayer Laboratories
• Veru
• The Cooper Companies
• Church & Dwight
• Pfizer
• Ansell
• Bayer
• Merck
• Teva Pharmaceutical Industries Limited
• AbbVie

Contraceptive Market by Segment
The study includes a forecast for the global contraceptive market by product type, age group, end use, and region.
Contraceptive Market by Product Type [Value from 2019 to 2031]:
• Drugs
• Devices

Contraceptive Market by Age Group [Value from 2019 to 2031]:
• 15-44 Years
• Above 44 Years

Contraceptive Market by Region [Value from 2019 to 2031]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Contraceptive Market
The contraceptive market is experiencing a rapid change all over the world, facilitated by a growing focus on reproductive health, female empowerment, and changing social expectations around family planning. New developments are resulting in wider, more accessible, and convenient contraceptive choices, such as long-acting reversible contraceptives (LARCs), non-hormonal alternatives, and digital health technologies. This changing market is also driven by government policies, awareness campaigns, and technological innovations to meet unmet demands for contraception and minimize unintended pregnancies globally. Ongoing innovation in new products and delivery options highlights the market's passion for offering efficient and tailored birth control options.
• United States: The US market for contraceptives has witnessed major advancements, with the July 2023 approval of Opal, a daily oral contraceptive available over-the-counter, as the first non-prescription option. This makes it much more accessible. There remains strong demand for long-acting reversible contraceptives (LARCs) such as IUDs and implants with high effectiveness and ease of use. Furthermore, the market is typified by continuous research into new non-hormonal products and male contraceptives, indicating a preference for differentiated options and joint responsibility in family planning. Favorable reimbursement policies also drive product adoption.
• China: China's contraceptive market has been impacted greatly by the transition from the one-child, to the two-child, and later the three-child policy, resulting in a higher emphasis being placed on contraceptives that enable greater family planning and child spacing. The current trends indicate a dominant market share for contraceptive devices, with IUDs leading the way, which have always been popular. There is also increasing prevalence of oral contraceptives, which are frequently sold over-the-counter. Government policies and growing awareness of family planning drive product demand and distribution channels among the large population.
• Germany: The market for contraceptives in Germany is sophisticated and mature with high levels of awareness of reproductive health and diversified product offerings. Recent trends reflect sustained demand for hormonal contraceptives like oral pills, vaginal rings, and implants. There is growing uptake of long-acting reversible contraceptives (LARCs) on account of their efficiency and convenience. The market is favored by a strong healthcare system and aggressive health education programs. Evolving lifestyles, with more women waiting to get pregnant and choosing small families, also support a consistent demand for efficient birth control measures.
• India: India's market for contraceptives is growing fast, fueled by government efforts to stem population growth and raise family planning awareness, particularly in rural regions. Recent trends have been the launch of new contraceptive products such as sub-dermal implants and subcutaneous injections under national family planning programs to advance reproductive and sexual health. There has been increasing demand for hormonal and non-hormonal products, with the oral contraceptive pill being popular. Initiatives by public health campaigns and non-governmental organizations are imperative in enhancing access and diminishing unmet needs for contraception.
• Japan: The contraceptive market of Japan is comparatively smaller yet maintains steady growth owing to changing social attitudes toward family planning and greater awareness of reproductive health. Recent trends reflect growing demand for oral contraceptives and condoms, the most widely used methods owing to convenience of use and cultural acceptability. There is also a rising interest in emergency contraceptive pills, particularly among younger women. Government educational programs aimed at raising awareness about contraception among the youth are gradually increasing adoption rates and diversifying the range of available options.

Features of the Global Contraceptive Market
Market Size Estimates: Contraceptive market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Contraceptive market size by product type, age group, end use, and region in terms of value ($B).
Regional Analysis: Contraceptive market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, age groups, end uses, and regions for the contraceptive market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the contraceptive market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the contraceptive market by product type (drugs and devices), age group (15-44 years and above 44 years), end use (households, clinics, and hospitals), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

ページTOPに戻る

Table of Contents

Table of Contents

1. Executive Summary

2. Market Overview
2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis
3.1 Global Contraceptive Market Trends and Forecast
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Contraceptive Market by Product Type
4.1 Overview
4.2 Attractiveness Analysis by Product Type
4.3 Drugs: Trends and Forecast (2019-2031)
4.4 Devices: Trends and Forecast (2019-2031)

5. Global Contraceptive Market by Age Group
5.1 Overview
5.2 Attractiveness Analysis by Age Group
5.3 15-44 Years: Trends and Forecast (2019-2031)
5.4 Above 44 Years: Trends and Forecast (2019-2031)

6. Global Contraceptive Market by End Use
6.1 Overview
6.2 Attractiveness Analysis by End Use
6.3 Households: Trends and Forecast (2019-2031)
6.4 Clinics: Trends and Forecast (2019-2031)
6.5 Hospitals: Trends and Forecast (2019-2031)

7. Regional Analysis
7.1 Overview
7.2 Global Contraceptive Market by Region

8. North American Contraceptive Market
8.1 Overview
8.2 North American Contraceptive Market by Product Type
8.3 North American Contraceptive Market by End Use
8.4 United States Contraceptive Market
8.5 Mexican Contraceptive Market
8.6 Canadian Contraceptive Market

9. European Contraceptive Market
9.1 Overview
9.2 European Contraceptive Market by Product Type
9.3 European Contraceptive Market by End Use
9.4 German Contraceptive Market
9.5 French Contraceptive Market
9.6 Spanish Contraceptive Market
9.7 Italian Contraceptive Market
9.8 United Kingdom Contraceptive Market

10. APAC Contraceptive Market
10.1 Overview
10.2 APAC Contraceptive Market by Product Type
10.3 APAC Contraceptive Market by End Use
10.4 Japanese Contraceptive Market
10.5 Indian Contraceptive Market
10.6 Chinese Contraceptive Market
10.7 South Korean Contraceptive Market
10.8 Indonesian Contraceptive Market

11. ROW Contraceptive Market
11.1 Overview
11.2 ROW Contraceptive Market by Product Type
11.3 ROW Contraceptive Market by End Use
11.4 Middle Eastern Contraceptive Market
11.5 South American Contraceptive Market
11.6 African Contraceptive Market

12. Competitor Analysis
12.1 Product Portfolio Analysis
12.2 Operational Integration
12.3 Porter’s Five Forces Analysis
• Competitive Rivalry
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Threat of Substitutes
• Threat of New Entrants
12.4 Market Share Analysis

13. Opportunities & Strategic Analysis
13.1 Value Chain Analysis
13.2 Growth Opportunity Analysis
13.2.1 Growth Opportunities by Product Type
13.2.2 Growth Opportunities by Age Group
13.2.3 Growth Opportunities by End Use
13.3 Emerging Trends in the Global Contraceptive Market
13.4 Strategic Analysis
13.4.1 New Product Development
13.4.2 Certification and Licensing
13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain
14.1 Competitive Analysis
14.2 Mayer Laboratories
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.3 Veru
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.4 The Cooper Companies
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.5 Church & Dwight
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.6 Pfizer
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.7 Ansell
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.8 Bayer
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.9 Merck
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.10 Teva Pharmaceutical Industries Limited
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing
14.11 AbbVie
• Company Overview
• Contraceptive Business Overview
• New Product Development
• Merger, Acquisition, and Collaboration
• Certification and Licensing

15. Appendix
15.1 List of Figures
15.2 List of Tables
15.3 Research Methodology
15.4 Disclaimer
15.5 Copyright
15.6 Abbreviations and Technical Units
15.7 About Us
15.8 Contact Us

List of Figures

Chapter 1
Figure 1.1: Trends and Forecast for the Global Contraceptive Market
Chapter 2
Figure 2.1: Usage of Contraceptive Market
Figure 2.2: Classification of the Global Contraceptive Market
Figure 2.3: Supply Chain of the Global Contraceptive Market
Chapter 3
Figure 3.1: Driver and Challenges of the Contraceptive Market
Figure 3.2: PESTLE Analysis
Figure 3.3: Patent Analysis
Figure 3.4: Regulatory Environment
Chapter 4
Figure 4.1: Global Contraceptive Market by Product Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Contraceptive Market ($B) by Product Type
Figure 4.3: Forecast for the Global Contraceptive Market ($B) by Product Type
Figure 4.4: Trends and Forecast for Drugs in the Global Contraceptive Market (2019-2031)
Figure 4.5: Trends and Forecast for Devices in the Global Contraceptive Market (2019-2031)
Chapter 5
Figure 5.1: Global Contraceptive Market by Age Group in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Contraceptive Market ($B) by Age Group
Figure 5.3: Forecast for the Global Contraceptive Market ($B) by Age Group
Figure 5.4: Trends and Forecast for 15-44 Years in the Global Contraceptive Market (2019-2031)
Figure 5.5: Trends and Forecast for Above 44 Years in the Global Contraceptive Market (2019-2031)
Chapter 6
Figure 6.1: Global Contraceptive Market by End Use in 2019, 2024, and 2031
Figure 6.2: Trends of the Global Contraceptive Market ($B) by End Use
Figure 6.3: Forecast for the Global Contraceptive Market ($B) by End Use
Figure 6.4: Trends and Forecast for Households in the Global Contraceptive Market (2019-2031)
Figure 6.5: Trends and Forecast for Clinics in the Global Contraceptive Market (2019-2031)
Figure 6.6: Trends and Forecast for Hospitals in the Global Contraceptive Market (2019-2031)
Chapter 7
Figure 7.1: Trends of the Global Contraceptive Market ($B) by Region (2019-2024)
Figure 7.2: Forecast for the Global Contraceptive Market ($B) by Region (2025-2031)
Chapter 8
Figure 8.1: North American Contraceptive Market by Product Type in 2019, 2024, and 2031
Figure 8.2: Trends of the North American Contraceptive Market ($B) by Product Type (2019-2024)
Figure 8.3: Forecast for the North American Contraceptive Market ($B) by Product Type (2025-2031)
Figure 8.4: North American Contraceptive Market by End Use in 2019, 2024, and 2031
Figure 8.5: Trends of the North American Contraceptive Market ($B) by End Use (2019-2024)
Figure 8.6: Forecast for the North American Contraceptive Market ($B) by End Use (2025-2031)
Figure 8.7: Trends and Forecast for the United States Contraceptive Market ($B) (2019-2031)
Figure 8.8: Trends and Forecast for the Mexican Contraceptive Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the Canadian Contraceptive Market ($B) (2019-2031)
Chapter 9
Figure 9.1: European Contraceptive Market by Product Type in 2019, 2024, and 2031
Figure 9.2: Trends of the European Contraceptive Market ($B) by Product Type (2019-2024)
Figure 9.3: Forecast for the European Contraceptive Market ($B) by Product Type (2025-2031)
Figure 9.4: European Contraceptive Market by End Use in 2019, 2024, and 2031
Figure 9.5: Trends of the European Contraceptive Market ($B) by End Use (2019-2024)
Figure 9.6: Forecast for the European Contraceptive Market ($B) by End Use (2025-2031)
Figure 9.7: Trends and Forecast for the German Contraceptive Market ($B) (2019-2031)
Figure 9.8: Trends and Forecast for the French Contraceptive Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Spanish Contraceptive Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Italian Contraceptive Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the United Kingdom Contraceptive Market ($B) (2019-2031)
Chapter 10
Figure 10.1: APAC Contraceptive Market by Product Type in 2019, 2024, and 2031
Figure 10.2: Trends of the APAC Contraceptive Market ($B) by Product Type (2019-2024)
Figure 10.3: Forecast for the APAC Contraceptive Market ($B) by Product Type (2025-2031)
Figure 10.4: APAC Contraceptive Market by End Use in 2019, 2024, and 2031
Figure 10.5: Trends of the APAC Contraceptive Market ($B) by End Use (2019-2024)
Figure 10.6: Forecast for the APAC Contraceptive Market ($B) by End Use (2025-2031)
Figure 10.7: Trends and Forecast for the Japanese Contraceptive Market ($B) (2019-2031)
Figure 10.8: Trends and Forecast for the Indian Contraceptive Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the Chinese Contraceptive Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the South Korean Contraceptive Market ($B) (2019-2031)
Figure 10.11: Trends and Forecast for the Indonesian Contraceptive Market ($B) (2019-2031)
Chapter 11
Figure 11.1: ROW Contraceptive Market by Product Type in 2019, 2024, and 2031
Figure 11.2: Trends of the ROW Contraceptive Market ($B) by Product Type (2019-2024)
Figure 11.3: Forecast for the ROW Contraceptive Market ($B) by Product Type (2025-2031)
Figure 11.4: ROW Contraceptive Market by End Use in 2019, 2024, and 2031
Figure 11.5: Trends of the ROW Contraceptive Market ($B) by End Use (2019-2024)
Figure 11.6: Forecast for the ROW Contraceptive Market ($B) by End Use (2025-2031)
Figure 11.7: Trends and Forecast for the Middle Eastern Contraceptive Market ($B) (2019-2031)
Figure 11.8: Trends and Forecast for the South American Contraceptive Market ($B) (2019-2031)
Figure 11.9: Trends and Forecast for the African Contraceptive Market ($B) (2019-2031)
Chapter 12
Figure 12.1: Porter’s Five Forces Analysis of the Global Contraceptive Market
Figure 12.2: Market Share (%) of Top Players in the Global Contraceptive Market (2024)
Chapter 13
Figure 13.1: Growth Opportunities for the Global Contraceptive Market by Product Type
Figure 13.2: Growth Opportunities for the Global Contraceptive Market by Age Group
Figure 13.3: Growth Opportunities for the Global Contraceptive Market by End Use
Figure 13.4: Growth Opportunities for the Global Contraceptive Market by Region
Figure 13.5: Emerging Trends in the Global Contraceptive Market

List of Tables

Chapter 1
Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Contraceptive Market by Product Type, Age Group, and End Use
Table 1.2: Attractiveness Analysis for the Contraceptive Market by Region
Table 1.3: Global Contraceptive Market Parameters and Attributes
Chapter 3
Table 3.1: Trends of the Global Contraceptive Market (2019-2024)
Table 3.2: Forecast for the Global Contraceptive Market (2025-2031)
Chapter 4
Table 4.1: Attractiveness Analysis for the Global Contraceptive Market by Product Type
Table 4.2: Market Size and CAGR of Various Product Type in the Global Contraceptive Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Product Type in the Global Contraceptive Market (2025-2031)
Table 4.4: Trends of Drugs in the Global Contraceptive Market (2019-2024)
Table 4.5: Forecast for Drugs in the Global Contraceptive Market (2025-2031)
Table 4.6: Trends of Devices in the Global Contraceptive Market (2019-2024)
Table 4.7: Forecast for Devices in the Global Contraceptive Market (2025-2031)
Chapter 5
Table 5.1: Attractiveness Analysis for the Global Contraceptive Market by Age Group
Table 5.2: Market Size and CAGR of Various Age Group in the Global Contraceptive Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Age Group in the Global Contraceptive Market (2025-2031)
Table 5.4: Trends of 15-44 Years in the Global Contraceptive Market (2019-2024)
Table 5.5: Forecast for 15-44 Years in the Global Contraceptive Market (2025-2031)
Table 5.6: Trends of Above 44 Years in the Global Contraceptive Market (2019-2024)
Table 5.7: Forecast for Above 44 Years in the Global Contraceptive Market (2025-2031)
Chapter 6
Table 6.1: Attractiveness Analysis for the Global Contraceptive Market by End Use
Table 6.2: Market Size and CAGR of Various End Use in the Global Contraceptive Market (2019-2024)
Table 6.3: Market Size and CAGR of Various End Use in the Global Contraceptive Market (2025-2031)
Table 6.4: Trends of Households in the Global Contraceptive Market (2019-2024)
Table 6.5: Forecast for Households in the Global Contraceptive Market (2025-2031)
Table 6.6: Trends of Clinics in the Global Contraceptive Market (2019-2024)
Table 6.7: Forecast for Clinics in the Global Contraceptive Market (2025-2031)
Table 6.8: Trends of Hospitals in the Global Contraceptive Market (2019-2024)
Table 6.9: Forecast for Hospitals in the Global Contraceptive Market (2025-2031)
Chapter 7
Table 7.1: Market Size and CAGR of Various Regions in the Global Contraceptive Market (2019-2024)
Table 7.2: Market Size and CAGR of Various Regions in the Global Contraceptive Market (2025-2031)
Chapter 8
Table 8.1: Trends of the North American Contraceptive Market (2019-2024)
Table 8.2: Forecast for the North American Contraceptive Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Product Type in the North American Contraceptive Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Product Type in the North American Contraceptive Market (2025-2031)
Table 8.5: Market Size and CAGR of Various End Use in the North American Contraceptive Market (2019-2024)
Table 8.6: Market Size and CAGR of Various End Use in the North American Contraceptive Market (2025-2031)
Table 8.7: Trends and Forecast for the United States Contraceptive Market (2019-2031)
Table 8.8: Trends and Forecast for the Mexican Contraceptive Market (2019-2031)
Table 8.9: Trends and Forecast for the Canadian Contraceptive Market (2019-2031)
Chapter 9
Table 9.1: Trends of the European Contraceptive Market (2019-2024)
Table 9.2: Forecast for the European Contraceptive Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Product Type in the European Contraceptive Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Product Type in the European Contraceptive Market (2025-2031)
Table 9.5: Market Size and CAGR of Various End Use in the European Contraceptive Market (2019-2024)
Table 9.6: Market Size and CAGR of Various End Use in the European Contraceptive Market (2025-2031)
Table 9.7: Trends and Forecast for the German Contraceptive Market (2019-2031)
Table 9.8: Trends and Forecast for the French Contraceptive Market (2019-2031)
Table 9.9: Trends and Forecast for the Spanish Contraceptive Market (2019-2031)
Table 9.10: Trends and Forecast for the Italian Contraceptive Market (2019-2031)
Table 9.11: Trends and Forecast for the United Kingdom Contraceptive Market (2019-2031)
Chapter 10
Table 10.1: Trends of the APAC Contraceptive Market (2019-2024)
Table 10.2: Forecast for the APAC Contraceptive Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Product Type in the APAC Contraceptive Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Product Type in the APAC Contraceptive Market (2025-2031)
Table 10.5: Market Size and CAGR of Various End Use in the APAC Contraceptive Market (2019-2024)
Table 10.6: Market Size and CAGR of Various End Use in the APAC Contraceptive Market (2025-2031)
Table 10.7: Trends and Forecast for the Japanese Contraceptive Market (2019-2031)
Table 10.8: Trends and Forecast for the Indian Contraceptive Market (2019-2031)
Table 10.9: Trends and Forecast for the Chinese Contraceptive Market (2019-2031)
Table 10.10: Trends and Forecast for the South Korean Contraceptive Market (2019-2031)
Table 10.11: Trends and Forecast for the Indonesian Contraceptive Market (2019-2031)
Chapter 11
Table 11.1: Trends of the ROW Contraceptive Market (2019-2024)
Table 11.2: Forecast for the ROW Contraceptive Market (2025-2031)
Table 11.3: Market Size and CAGR of Various Product Type in the ROW Contraceptive Market (2019-2024)
Table 11.4: Market Size and CAGR of Various Product Type in the ROW Contraceptive Market (2025-2031)
Table 11.5: Market Size and CAGR of Various End Use in the ROW Contraceptive Market (2019-2024)
Table 11.6: Market Size and CAGR of Various End Use in the ROW Contraceptive Market (2025-2031)
Table 11.7: Trends and Forecast for the Middle Eastern Contraceptive Market (2019-2031)
Table 11.8: Trends and Forecast for the South American Contraceptive Market (2019-2031)
Table 11.9: Trends and Forecast for the African Contraceptive Market (2019-2031)
Chapter 12
Table 12.1: Product Mapping of Contraceptive Suppliers Based on Segments
Table 12.2: Operational Integration of Contraceptive Manufacturers
Table 12.3: Rankings of Suppliers Based on Contraceptive Revenue
Chapter 13
Table 13.1: New Product Launches by Major Contraceptive Producers (2019-2024)
Table 13.2: Certification Acquired by Major Competitor in the Global Contraceptive Market